ÂÜÀòÂÒÂ×

Katharine Chorlton has over 20 years of experience in regulatory affairs. Katharine is currently the Senior Director and EU Head of Regulatory Affairs at Silence Therapeutics plc, a position they have held since July 2022. Prior to this, they served as the Director and EU Head of Regulatory Affairs at the same company from July 2020 to July 2022. Before joining Silence Therapeutics, Katharine worked as the Director of Regulatory Affairs, Europe at Premier Research from January 2017 to July 2020. Katharine also held the role of Regulatory Affairs Director at MedImmune from September 2008 to December 2016. Katharine started their career as a Regulatory Affairs Manager at Biogen Idec Ltd from April 2001 to August 2008. Prior to that, they worked as a Senior Regulatory Associate at Wyeth from September 1999 to April 2002, and as a Project Planning Associate at Shire Pharmaceuticals from July 1997 to August 1999.

Katharine Chorlton received their MSc in Regulatory Affairs from Cardiff University / Prifysgol Caerdydd, where they studied from 2003 to 2009. Prior to that, they attended The University of Sheffield for the duration of 1991 to 1995. However, the specific degree and field of study during their time at The University of Sheffield were not provided.